Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

AstraZeneca

Overview

The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.

Study Type

OBSERVATIONAL

Conditions

Gastrointestinal Hemorrhage Ulcer

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer confirmed by endoscopy

Outcomes

Primary Outcomes

Gastroprotective agent compliance

Time frame: At the end of 1 month

Secondary Outcomes

Clinical characteristics of those ulcers with NSAID

Time frame: At the end of 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.